Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04254172 · ClinicalTrials.gov registry record
A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy
A clinical trial, sponsored by Pfizer.
- Terminated
- Registry status
- 2
- Enrollment target
NCT04254172 is a clinical trial that was terminated before completion, run by Pfizer. The registered enrollment target is 2 participants.
The verdict
NCT04254172 was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this low interventional study is to collect data on everyday movement in boys with Duchenne muscular dystrophy (DMD) using wearable activity sensors. The activity sensors could provide useful information beyond what is currently collected by functional (movement, strength) assessments in clinic. This information can help with the understanding of the impact of DMD, and perhaps with how possible treatments can affect this impact.
Interventions
- DEVICE Activity Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2020-08-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04254172
The ClinicalTrials.gov registry entry for NCT04254172 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Activity Monitor is the first listed.
NCT04254172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04254172 about?
NCT04254172 is a clinical study titled "A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy". The purpose of this low interventional study is to collect data on everyday movement in boys with Duchenne muscular dystrophy (DMD) using wearable activity sensors. The activity sensors could provide useful information beyond what is currently collected by functional (movement, strength) assessments...
What is the current status of trial NCT04254172?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2020-02-19. Estimated completion is 2020-08-19.
What interventions are being tested in trial NCT04254172?
The interventions under investigation include: Activity Monitor (DEVICE).
Who is sponsoring clinical trial NCT04254172?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.